06.20.24 -- Is Excessive Pressure In The Feed Frame Causing You Problems?

Business leaders can enhance QC operations by adopting a holistic view of the quality ecosystem and embracing comprehensive modernization strategies. Explore four principles for greater QC lab agility.

Londa Ritchey shares invaluable insights derived from her extensive experience, shedding light on the pivotal role of fostering a strong quality culture in maintaining GMP compliance.

Review considerations for the series of characterizations necessary to ensure the efficacy of a packaging or device component and final drug delivery system.

Media fill experts provide an overview of what to consider when selecting media for aseptic process simulations, particularly regarding regulatory requirements and user requirement specification (URS).

Learn why proper training is vital in cleanroom cleaning and disinfection and how to develop and maintain a successful training initiative.

Industry experts discuss the recently revised Annex 1, including the concept of a contamination control strategy and what contamination controls mean when they work together to provide an answer.

‘Brick dust’ compounds require additional steps if spray drying is to yield a commercially attractive process. Explore three technologies for improving drug solubility in organic solvents for spray drying.

Dry powder capsules offer a compact, portable means for patients to receive treatment. Examine the challenges of dry powder formulation and unlock the potential of high-dose inhaled medications.

BsAbs’ dual specificity opens a wide range of applications. Understand why consistent production of structurally complex molecules that exhibit high yield and purity requires keen expertise and experience.

In analytical environments, precise weighing takes place inside containment where powders do not escape. The purpose of this paper is to measure the effectiveness of three vibration isolation strategies.

Access to digital solutions like in silico software products that help to decrease therapeutic time to market and get lifesaving drugs to patients faster and smarter remains a challenge in biopharma.

Explore how utilizing ICP-MS can help pharmaceutical companies ensure the safety and effectiveness of their products, ultimately benefiting both patients and the industry as a whole.

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company, a molecule in clinical Phase II / III trials.

As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb.